PD-L1 Expression on Circulating Tumour-Derived Microvesicles as a Complementary Tool for Stratification of High-Grade Serous Ovarian Cancer Patients

SIMPLE SUMMARY: PD-1/PD-L1 axis blockade immunotherapy leverages on assessment of tumour PD-L1 status by immunohistochemistry for identifying cancer patients’ who would benefit most from this therapy. Because some PD-L1 negative cancer patients also benefit from the treatment, it has been postulated...

Descripción completa

Detalles Bibliográficos
Autores principales: Battaglia, Alessandra, Piermattei, Alessia, Buzzonetti, Alexia, Pasciuto, Tina, Zampetti, Nicole, Fossati, Marco, Angelico, Giuseppe, Iacobelli, Valentina, Nero, Camilla, Iannucci, Veronica, Scambia, Giovanni, Fagotti, Anna, Fattorossi, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534085/
https://www.ncbi.nlm.nih.gov/pubmed/34680346
http://dx.doi.org/10.3390/cancers13205200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534085/
https://www.ncbi.nlm.nih.gov/pubmed/34680346
http://dx.doi.org/10.3390/cancers13205200

Ejemplares similares